@RheumNowi
iAccount based inUnited States
About this account
- Account based in
- United States
- Connected via
- United States App Store
Account-level information from X, not a live location or the device used for a specific post.
Know-it-Now. Info on RA, Stills disease, Lupus, Gout, Pregnancy, Spondylitis, Psoriasis, Drug Safety, Rheumatology Research, Medical Education & Drug Evaluation
Dallas, TX
Joined April 2011
- Tweets35.4K
- Following450
- Followers25.7K
- Likes752
Pinned Tweet
Obesity & Inflammation nitter.cf/i/broadcasts/1mGPaZPyk…
Discussing Weight Loss: 3 Minute Script
Dr. Jack Cush's 3 Minute Script as discussed in his Introducing Weight Loss video.
buff.ly/dSSvddI
🤖 Made with AI
Chinese 52 wk study of XKH004, a novel, SC, humanized anti-17A/F in 323 active AS pts Rx q4 wks vs PBO. @ Wk 16, XKH004 was superior for ASAS40 (45.4% vs 19.4%; P<0.001), improved to 66% by wk 52. buff.ly/6ZIzPu2
Obesity and Rheumatic Disease
Presented as part of RheumNow's "The Obesity Imperative" campaign.
buff.ly/uKTEYyR
Join us for Tuesday Nite Rheumatology on September 22 for:
Obesity Treatment & Safety
Experts will tackle:
• GLP-1/GIP therapies
• Lifestyle & bariatric interventions
• Treatment selection & safety
• Cost & compounding concerns
• Sarcopenia & bone health
• The future of precision obesity care
Featuring Dr. Juliana Simonetti and Dr. Grace Wright, moderated by Dr. Jack Cush.
📅 Sept. 22
⏰ 7 PM ET | 6 PM CT | 4 PM PT
buff.ly/znEw37u
🚨NEW FROM EULAR: In biologic-naive PsA, how do IL-23i, TNFi, and IL-17i compare on joint outcomes?
🦴Real-world data on TJC/SJC now available.
Sponsored by AbbVie Medical Affairs + Health Impact. buff.ly/TNRmi3V
Review of HLA-B27
What’s New? HLA-B27 remains the dominant genetic link to spondyloarthritis (SpA) across the age spectrum, but B27 related clinical expression diverges between children and adults. New mechanistic data on autoreactive T cells, HLA-B27 misfolding, and gut-joint trafficking point to new plausible, targetable pathways.
buff.ly/MAIQw7Q
Added IVIG is Effective in Myositis
A small randomized controlled trial demonstrates that intravenous immunoglobulin (IVIG) added to cortocosteroids lead to greater and faster improvements in patients with newly diagnosed idiopathic inflammatory myopathies (IIMs).
buff.ly/lO2TUmm
Bariatric Surgery in the Era of GLP-1RA
Overweight/obesity is a chronic multi-system disease that can impair physical and mental health. It now affects almost 1 in 3 Canadians. Multiple recent guidelines have therefore suggested using waist measurements, in addition to BMI, to diagnose obesity. One such measure is the waist-to-height ratio, with a value above 0.5 indicating increased adiposity.
buff.ly/DkrkSGE
4,197 pts from the UK Biobank met fibromyalgia criteria, yet 72.6% had NOT received a diagnosis. Non-Dx assoc w/ male, older age, milder sxs or other pain Dx (OA, CRPS, CFS), lower polysymptomatic distress scores, and less frequent fatigue. buff.ly/pAVWEtQ
Research at Cedars-Sinai used synthetic noncoding RNA TY1 in a bleomycin mouse model of scleroderma, noting improved exercise tolerance, CV function, lung hydroxyproline, skin thickness, less fibrosis. TY1 attenuates the cGAS/STING pathway buff.ly/DW56x3o
OL study of tofacitinib in 20 juvenile DM pts w/ calcinosis cutis (11 boys; age 10.4 yrs; CC x 31 mos). Calcinosis assessed by CT scan showed decr Agatston score from 6,349 to 4,007. No SAE. buff.ly/GSEhoJQ
Join us for Tuesday Nite Rheumatology on September 22 for:
🔴 Obesity Treatment & Safety
Experts will tackle:
• GLP-1/GIP therapies
• Lifestyle & bariatric interventions
• Treatment selection & safety
• Cost & compounding concerns
• Sarcopenia & bone health
• The future of precision obesity care
Featuring Dr. Juliana Simonetti and Dr. Grace Wright, moderated by Dr. Jack Cush.
📅 Sept. 22
⏰ 7 PM ET | 6 PM CT | 4 PM PT
buff.ly/znEw37u
Metanalysis of 87 studies shows predictors of #MTX response: early Dz, low dz activity, early MTX initiation, and absence of erosive disease. Smoking and higher BMI were linked to reduced efficacy. buff.ly/8FevLWF
Obesity and Rheumatic Disease
Presented as part of RheumNow's "The Obesity Imperative" campaign.
buff.ly/uKTEYyR
QD Clinic: GLP-1s and History of Thyroid Cancer?
Daric Mueller, PA-C, St. Clair Shores, MI, presents this case as part of RheumNow's "The Obesity Imperative" campaign, presented in September 2026.
buff.ly/0ltVb1O
Early RA Referral Clinics Work!
An outcomes study from the Leiden Early Arthritis Clinic (EAC) has shown substantially less diagnostic delay and better long-term outcomes when patients are referred to EAC compared to usual referrals.
buff.ly/YqT9UwA
Obesity management goes far beyond the number on the scale.
Watch our Four Pillars of Weight Loss video series, part of this month’s The Obesity Imperative campaign.
What Are the Four Pillars of Obesity Management?
Building a Multidisciplinary Program for Obesity & Arthritis Management
Explore how a comprehensive, multidisciplinary approach can help reshape obesity care in rheumatology.
buff.ly/LrWGynZ
QD Clinic: Bariatric Surgery "Curing" Arthritis?
Dr. Richard Conway, Dublin, presents this QD Clinic as part of RheumNow's "The Obesity Imperative" campaign, presented in September 2026.
buff.ly/GDZy8zy
Obesity Journal Club: Tuesday Nite Rheumatology
The Obesity Journal Club explores the TOGETHER PsA and STEP 9 trials and what emerging evidence tells us about the relationship between obesity, weight loss, and rheumatic disease. Panelists discussed the results of these trials, how we consider obesity as both a comorbidity and part of the disease course, and shared practical strategies for addressing obesity in everyday rheumatology practice.
buff.ly/WdZC9VN
Obesity and Rheumatic Disease
Presented as part of RheumNow's "The Obesity Imperative" campaign.
buff.ly/uKTEYyR